
FDA issues urgent recall for cucumbers contaminated with deadly bacteria salmonella
On Tuesday, the FDA upgraded its June 16 alert to the highest level when it recalled 71 boxes of the vegetable from Fuentes Farms in McAllen, Texas.
Nearly 3,000lb of produce was potentially contaminated with a fatal form of the bacteria, which could cause food poisoning or death if the infection spread to the bloodstream or caused severe dehydration.
Other symptoms included diarrhea, fever, and stomach cramps, which could be serious for young children, the elderly, or those with weakened immune systems.
Fuentes Farms revealed that the recall affected 40lb boxes of cucumbers with the code 357.
The produce was sold by vendors at markets in the McAllen and Alamo areas of Texas.
If the cucumbers were handled by vendors and customers without taking proper hygiene into account, the bacteria could easily spread to other foods and people in the outdoor markets.
The FDA found the salmonella during a routine sampling of the company's produce in June.
Fuentes Farms had since stopped production and distribution of cucumbers as the FDA continued its investigation into the problem.
In a statement released by the FDA, Fuentes Farms said: 'Consumers who believe they may have purchased cucumbers from Lot #357 are advised to dispose of the product or return it to the place of purchase.'
So far, no illnesses had been reported and health officials had not discovered any salmonella outbreaks linked to this recall.
Fuentes Farms noted that the cucumbers were distributed and sold from May 31 to June 3.
According to the FDA and the Centers For Disease Control And Prevention, salmonella's one of the leading causes of foodborne illnesses in the U.S., and produce-related outbreaks were often tied to contamination from water, soil or improper handling.
A 2017 study in Food Protection Trends found that unsafe handling of raw meat and unwashed fruit and veg significantly increased the risk of both E coli and salmonella.
Cucumbers were implicated in several outbreaks in recent years, though they're not as frequent a source as leafy greens or poultry.
According to experts, refrigerators could become a breeding ground for disease.
Professor Judith Evans from London South Bank University and researcher at the Quadram Institute Oleksii Omelchenko told news site The Conversation: 'Part of the problem is that many refrigerators lack an accurate, accessible way to monitor their internal temperature.
'On top of that, every time you open the door, warm air rushes in. The longer the door stays open - especially if you're lingering while choosing a snack - the more the internal temperature climbs toward room temperature, creating a more suitable environment for bacteria to thrive.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
3 minutes ago
- Reuters
Precigen shares jump after US FDA approves first therapy for rare respiratory disease
Aug 15 (Reuters) - Precigen's (PGEN.O), opens new tab immunotherapy for a rare respiratory disease has become the first treatment to win U.S. regulatory approval for the condition, which typically requires frequent surgeries, sending the company's shares soaring 83% on Friday. The U.S. Food and Drug Administration has approved the therapy, Papzimeos, to treat adults with recurrent respiratory papillomatosis (RRP) — a condition that causes growth of benign tumors in the respiratory tract due to human papillomavirus (HPV) infection. A distinguishing aspect of RRP is the tendency for the tumors to return even after removing them through surgical procedures. The disease can be fatal as there is no cure. The FDA approval was based on an early-to-mid-stage study data that showed 51% of patients required no surgeries in the 12 months after the treatment. "Randomized trials are not always needed to approve medical products and this approval is proof of that philosophy," said Vinay Prasad, who recently returned to the FDA to oversee vaccine, gene therapy and blood product regulation. Papzimeos is designed to stimulate an immune response against cells infected with HPV types 6 and 11 — the strains that cause the disease. H.C. Wainwright analysts estimate peak sales of the drug to reach $1.1 billion in 2033. "We may finally be able to say no more surgery," said Kim McClellan, president of the Recurrent Respiratory Papillomatosis Foundation. McClellan herself was diagnosed with RRP at the age of five and has since then had more than 250 surgeries. Precigen estimates about 27,000 adult RRP patients in the U.S. It did not immediately respond to a Reuters request for comment on the treatment's pricing. Simon Best, associate professor of Otolaryngology at Johns Hopkins Hospital, said patients were eagerly awaiting a new treatment. "There's nothing more frustrating than doing a surgery and then having the patient come back six months later."


Reuters
34 minutes ago
- Reuters
Pfizer's sickle cell drug fails main goal in late-stage trial
Aug 15 (Reuters) - Pfizer (PFE.N), opens new tab said on Friday that its experimental sickle cell disease drug failed to meet the main goal in a late stage trial in patients 16 years of age and older.


Reuters
34 minutes ago
- Reuters
Pfizer's sickle cell drug fails late-stage trial
Aug 15 (Reuters) - Pfizer's (PFE.N), opens new tab experimental drug to treat sickle cell anemia failed to meet the main goal in a late stage trial, the drugmaker said on Friday. Results showed no significant difference between the number of vaso-occlusive crises — painful events common in sickle cell disease — among people who took the drug, named inclacumab, and those who took placebo. Pfizer said it is disappointed by the results but remains committed to supporting the sickle cell community. Inclacumab was generally well tolerated in the trial that included patients 16 years of age and older, the company said. The most common side effects reported were anemia, joint pain, back pain, headache, malaria, sickle cell crisis and upper respiratory tract infection, it said. The disease is an inherited blood disorder in which red blood cells become sickle- or crescent-shaped and can cause strokes, organ damage and death.